Bloomberg the Company

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Follow Us

Industry Products

  • Exchange: Frankfurt
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

KA6:GR

0.060 EUR 0.0000.00%

As of 03:18:11 ET on 02/27/2015.

Snapshot for Karo Bio AB (KA6)

Open: 0.075 Day's Range: 0.060 - 0.075 Volume: 0
Previous Close: 0.060 52wk Range: 0.023 - 0.181 1-Yr Rtn: +20.00%

Stock Chart for KA6

No chart data available.
  • KA6:GR 0.060
  • 1D
  • 1M
  • 1Y
0.060
Interactive KA6 Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for KA6

Current P/E Ratio (ttm) -
Estimated P/E(12/2015) -
Relative P/E vs. DAX -
Earnings Per Share (SEK) (ttm) -
Est. EPS (SEK) (12/2015) -
Est. PEG Ratio -
Market Cap (M EUR) 40.58
Shares Outstanding (M) 676.26
30 Day Average Volume 465
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 05/08/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for KA6

  • Revenue
  • Net Income (M/SEK)
  • Profit Margin (%)

Company Profile & Key Executives for KA6

Karo Bio AB operates a drug research and development company. The Company develops precision drugs to treat major diseases in the field of nuclear receptors. Karo Bio works within many therapeutic areas including men and women's health, cardiovascular diseases, metabolic disorders and dermatology.

Anders LonnerChairmanMaria SjoebergChief Executive Officer
Henrik PalmExec Vice PresidentAnneli HallgrenChief Scientific Ofcr/VP:Dvpt
More Company Profile & Key Executives for KA6

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil